Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
ORIC-101(一种糖皮质激素受体拮抗剂)与恩杂鲁胺联合治疗恩杂鲁胺治疗期间病情进展的转移性去势抵抗性前列腺癌患者的 I 期研究
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-23-3508
Wassim Abida, Andrew W Hahn, Neal Shore, Neeraj Agarwal, Paul Sieber, Matthew R Smith, Tanya Dorff, Paul Monk, Matthew Rettig, Rupal Patel, Anne Page, Maureen Duff, Rongda Xu, Jian Wang, Shravani Barkund, Aleksandr Pankov, Amber Wang, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow